Jump to content

Drilldown: Medicines

Nav

Choose a table:

Medicines (732)

Medicines > classes

: Dissociative

or Lysergamide

or Stimulant

Use the filters below to narrow your results.

None (71) · Benzedrex (1) · Delysid (historical, Sandoz, withdrawn 1965) (1) · DXM (1) · DXO (1) · Spravato (1)

Monoamine releasing agent (8) · Dopamine/norepinephrine reuptake inhibitor (5) · LSD analogue; 5-HT2A agonist (4) · Prodrug of LSD; 5-HT2A agonist (4) · NMDA antagonist (3) · Cathinone analogue; monoamine reuptake inhibitor (2) · Dopamine and norepinephrine reuptake inhibitor (2) · NMDA antagonist; sigma receptor agonist (2) · Norepinephrine–dopamine reuptake inhibitor (2)

Other values:

None (75) · Treatment-resistant depression (TRD) in adults, as adjunct to oral antidepressant (FDA-approved March 2019). Depressive symptoms in adults with MDD with acute suicidal ideation or behavior (FDA-approved Aug 2020). (1)

None (75) · Induction (TRD): 56 mg intranasal twice weekly × 4 weeks. Maintenance: 56-84 mg once weekly × 4 weeks, then 56-84 mg every 1-2 weeks. For acute suicidality: 84 mg twice weekly × 4 weeks. Administered under medical supervision in REMS-certified site. (1)

None (75) · 28 mg/device (each dose uses 2 devices) (1)

None (75) · 84 mg per session (1)

None (74) · Intranasal (under direct medical supervision) (1) · Oral (1)

None (74) · 30–60 minutes (1) · Within hours of first administration (1)

None (74) · 8–12 hours (1) · Acute effect ~24 hours; cumulative effect builds with repeated dosing (1)

None (74) · 3–5 hours (1) · ~7-12 hours (1)

None (74) · 70–90% (oral) (1) · ~48% intranasal (1)

None (74) · Avoid; may cause fetal harm (1) · Not established (1)

None (74) · Rx, Schedule III (US). REMS program required. (1) · Schedule I (United States) (1)

Showing below up to 76 results in range #1 to #76.

1

2

3

4

A

B

Bromantane

C

D

E

H

Hexedrone

I

L

M

N

O

O-PCE

P

R

RTI-111

S

T

X

Xenon

Retrieved from "https://pharmacopedia.wiki/p/Special:Drilldown/Medicines"